Examinations with Donalgin in locomotor diseases treated at the out-patient department.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007592:Joint Diseases / Q000188:drug therapy*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009544:Niflumic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D009544:Niflumic Acid; D007213:Indomethacin